SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-001109
Filing Date
2018-01-16
Accepted
2018-01-16 20:08:20
Documents
2
Period of Report
2018-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5707
2 EX-24 DOCUMENT attachment1.htm EX-24 3874
  Complete submission text file 0000899243-18-001109.txt   11063
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Patel Kinnari (Reporting) CIK: 0001725929 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 18529624